• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears Elscint's TransACT protocol

Article

Elscint has received 510(k) clearance for its TransACT attenuation-correctiontechnique for the CardiaL 90° dual-head gamma camera. Clinicianshave been testing TransACT at Duke University Medical Center inDurham, NC, for its ability to correct

Elscint has received 510(k) clearance for its TransACT attenuation-correctiontechnique for the CardiaL 90° dual-head gamma camera. Clinicianshave been testing TransACT at Duke University Medical Center inDurham, NC, for its ability to correct inferior wall artifactscommon in myocardial imaging with thallium. The company is planningto adapt the technique for the adjustable-angle Varicam cameraas well.

Elscint also announced this month that it has received clearancefor its 2-tesla Prestige MRI scanner.

Recent Videos
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Related Content
© 2025 MJH Life Sciences

All rights reserved.